ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,217Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 1000

$743K Total Retail Price of All Prescriptions

Rank: 127 out of 1000

461 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 461 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 461 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 12,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,099 782 S3 1 1
AMLODIPINE BESYLATE 759 591 2 6
OMEPRAZOLE 683 489 3 2
SIMVASTATIN 517 434 4 3
LEVOTHYROXINE SODIUM 447 349 5 4
ATORVASTATIN CALCIUM 411 342 6 18
FUROSEMIDE 376 292 7 7
BISOPROLOL-HYDROCHLOROTHIAZIDE 356 293 8 101
ATENOLOL 355 299 9 24
GABAPENTIN 328 226 10 11
SERTRALINE HCL 317 240 11 26
METFORMIN HCL ER 290 234 12 44
CARVEDILOL 288 227 13 15
GLIMEPIRIDE 286 248 14 34
RANITIDINE HCL 284 210 15 37
LISINOPRIL 280 231 16 5
METFORMIN HCL 268 227 17 8
LOSARTAN POTASSIUM 249 186 18 25
METOPROLOL SUCCINATE 235 220 19 21
TRAMADOL HCL 226 137 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 215 188 21 20
DIGOXIN 205 202 22 52
ZOLPIDEM TARTRATE 201 147 23 16
MELOXICAM 192 170 24 14
LOSARTAN-HYDROCHLOROTHIAZIDE 190 133 25 38
PROMETHAZINE HCL 179 53 R 26 54
CITALOPRAM HBR 170 100 27 17
WARFARIN SODIUM 165 162 28 22
DOXYCYCLINE HYCLATE 151 102 29 97
ETODOLAC 146 100 30 152
POTASSIUM CHLORIDE 146 119 30 10
NEXIUM 146 104 30 23
FLUOXETINE HCL 137 77 33 51
DOXAZOSIN MESYLATE 137 124 33 111
PREDNISONE 120 97 35 42
NORTRIPTYLINE HCL 111 56 36 251
PLAVIX 111 100 36 49
DONEPEZIL HCL 109 106 38 32
MIRTAZAPINE 104 86 39 56
THEOPHYLLINE ANHYDROUS 100 83 40 186
CIPROFLOXACIN HCL 100 85 40 46
CLOPIDOGREL 100 82 40 35
CARISOPRODOL 100 39 R 40 72
FLUTICASONE PROPIONATE 96 66 44 40
PANTOPRAZOLE SODIUM 95 60 45 28
FLUCONAZOLE 88 36 46 102
CEFUROXIME 88 64 46 133
RISPERIDONE 85 37 48 87
PROAIR HFA 85 40 48 50
PRAVASTATIN SODIUM 83 34 50 12
TRAZODONE HCL 81 40 51 29
VENTOLIN HFA 80 38 52 83
MECLIZINE HCL 77 62 53 80
ALLOPURINOL 76 74 54 31
ACTOS 76 76 54 119
KLOR-CON 10 75 67 56 104
MONTELUKAST SODIUM 74 42 57 132
AMITRIPTYLINE HCL 71 44 R 58 45
LYRICA 70 38 59 47
TRIAMTERENE-HCTZ 65 65 60 48
CYMBALTA 64 38 61 53
TAMSULOSIN HCL 62 48 62 33
JANUVIA 62 37 62 85
AMLODIPINE BESYLATE-BENAZEPRIL 61 51 64 59
SINGULAIR 60 37 65 84
DOXEPIN HCL 58 39 66 176
TOPIRAMATE 57 0 67 181
BENAZEPRIL HCL 57 45 67 61
BISOPROLOL FUMARATE 57 52 67 209
CRESTOR 57 53 67 30
CYCLOBENZAPRINE HCL 56 17 R 71 39
ADVAIR DISKUS 56 50 71 65
AZITHROMYCIN 56 31 71 36
NAMENDA 54 54 74 43
DIOVAN 53 35 75 67
ATENOLOL-CHLORTHALIDONE 52 52 76 206
HYDROCHLOROTHIAZIDE 52 52 76 9
AVODART 51 45 78 214
SPIRIVA 50 43 79 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.